ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 1 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,110 | -38.7% | 10,112 | -24.5% | 0.00% | -33.3% |
Q2 2023 | $89,881 | +26028.2% | 13,395 | -65.6% | 0.00% | -72.7% |
Q1 2023 | $344 | +5633.3% | 38,978 | +4485.6% | 0.01% | – |
Q4 2022 | $6 | -100.0% | 850 | -95.8% | 0.00% | -100.0% |
Q3 2022 | $143,000 | +376.7% | 20,114 | +437.1% | 0.00% | +100.0% |
Q2 2022 | $30,000 | -89.7% | 3,745 | -82.0% | 0.00% | -66.7% |
Q1 2022 | $290,000 | +1160.9% | 20,840 | +2460.2% | 0.00% | – |
Q4 2021 | $23,000 | -51.1% | 814 | -40.8% | 0.00% | -100.0% |
Q3 2021 | $47,000 | -87.4% | 1,374 | -84.9% | 0.00% | -90.0% |
Q2 2021 | $372,000 | +530.5% | 9,108 | +524.3% | 0.01% | +900.0% |
Q1 2021 | $59,000 | -83.0% | 1,459 | -75.1% | 0.00% | -90.9% |
Q4 2020 | $347,000 | +638.3% | 5,860 | +501.6% | 0.01% | +1000.0% |
Q3 2020 | $47,000 | -39.7% | 974 | -39.4% | 0.00% | -66.7% |
Q2 2020 | $78,000 | +3800.0% | 1,606 | +2874.1% | 0.00% | – |
Q3 2019 | $2,000 | – | 54 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |